PreciseOnco Research Consortium Awarded EUR 14.9 Million IHI Grant to Drive Breakthroughs in Precision Cancer Treatment

Royal Philips has been awarded funding from the EU’s Innovative Health Initiative (IHI) to advance precision cancer treatment through the integration of advanced medical imaging, robotic assistance, and minimally invasive therapies.